CareDx, Inc
CareDx, Inc (CDNA) Revenue
Annual & quarterly revenue history · segment & region breakdown
CDNA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCareDx, Inc trailing twelve-month (TTM) revenue is $0.41B, an increase of 13.79% year-over-year from $0.38B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.38B | +$0.05B | +13.79% |
| 2024-12-31 | $0.33B | +$0.05B | +19.07% |
| 2023-12-31 | $0.28B | -$0.04B | -12.89% |
| 2022-12-31 | $0.32B | +$0.03B | +8.57% |
| 2021-12-31 | $0.30B | +$0.10B | +54.22% |
| 2020-12-31 | $0.19B | +$0.07B | +51.25% |
| 2019-12-31 | $0.13B | +$0.05B | +65.95% |
| 2018-12-31 | $0.08B | +$0.03B | +58.45% |
| 2017-12-31 | $0.05B | +$0.01B | +18.93% |
| 2016-12-31 | $0.04B | +$0.01B | +44.37% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare CDNA revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income CareDx, Inc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
CareDx, Inc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from CareDx, Inc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CDNA revenue · 4 questionsCDNA's trailing twelve-month (TTM) revenue is $0.41B. That is an increase of 13.79% year-over-year from $0.38B in FY2025.
▸ Source: FMP · CareDx, Inc SEC filings · GAAP · CareDx, Inc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026